Form 4 for WVE Wave Life Sciences, Inc.
Accepted 2025-08-13 00:00:00 ET · period of report 2025-08-11 · accession 0000950170-25-108291 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-13 | 2025-08-11 | WVE | CORRIGAN MARK | Dir | A - Grant | $0.00 | +12.7K | 44.9K | +39% | $0 |
| D | 2025-08-13 | 2025-08-11 | WVE | CORRIGAN MARK | Dir | A - Grant | $0.00 | +76.2K | 76.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-08-11 | A | A | 12,700 | $0.00 | 44,930 | D | — | — | (F1) The reporting person was granted this restricted share unit award (RSU) pursuant to the 2025 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2026 annual general meeting or August 11, 2026. |
| 2 | Derivative | Share Option (right to buy) | 2025-08-11 | A | A | 76,200 | $0.00 | 76,200 | D | $8.11 · — to 2030-08-11 | 76,200 Ordinary Shares | (F2) The reporting person was granted this option pursuant to the 2025 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2026 annual general meeting or August 11, 2026. |